| [1] |
Cushman M. Epidemiology and risk factors for venous thrombosis[J]. Semin Hematol, 2007, 44(2): 62-69.
|
| [2] |
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association[J]. Circulation, 2017, 135: e146-e603.
|
| [3] |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087.
|
| [4] |
Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and inhospital mortality from VTE, 2007 to 2016, in China[J]. Chest, 2019, 155(2): 342353.
|
| [5] |
刘凤林, 秦净. 从指南到实践:解析《中国普通外科围手术期血栓预防与管理指南》[J]. 协和医学杂志, 2018, 9(2): 144-149.
|
| [6] |
Hill J, Treasure T. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance[J]. BMJ, 2010, 340: c95.
|
| [7] |
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed；American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e278S-e325S.
|
| [8] |
Kumar DR, Hanlin E, Glurich I, et al．Virchow's contribution to the understanding of thrombosis and cellular biology[J]．Clin Med Res, 2010, 8(3/4): 168-172．
|
| [9] |
Kingsnorth A, LeBlanc K. Hernias: inguinal and incisional[J]. Lancet, 2003, 362(9395): 1561-1571.
|
| [10] |
Fitzgibbons RJ Jr. , Ramanan B, Arya S, et al. Long-term results of a randomized controlled trial of a nonoperative strategy(watchful waiting) for men with minimally symptomatic inguinal hernias[J]. Ann Surg, 2013, 258(3): 508-515.
|
| [11] |
Alhassan S, Pelinescu A, Gandhi V, et al. Clinical presentation and risk factors of venous thromboembolic disease[J]. Crit Care Nurs Q, 2017, 40(3): 201-209.
|
| [12] |
Liss D. Hypercoagulability and adrenal dysfunction in critical care[J]. Vet Technician, 2010, 31(8): E1-E3.
|
| [13] |
Lind C, Flinterman LE, Enga KF, et al. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases[J]. Circulation, 2014, 129: 855-863.
|
| [14] |
Mulder FI, Horváth-Puhó E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study[J]. Blood, 2021, 137(14): 1959-1969.
|
| [15] |
Falanga A, Schieppati F, Russo L. Pathophysiology 1. Mechanisms of thrombosis in cancer patients[J]. Cancer Treat Res, 2019, 179: 11-36.
|
| [16] |
Falanga A, Ay C, Di Nisio M, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline[J]. Ann Oncol, 2023, 34(5): 452-467.
|
| [17] |
Dong W, Zhu Y, Du Y, et al. Association between features of COPD and risk of venous thromboembolism[J]. Clin Respir J, 2019, 13(8): 499-504.
|
| [18] |
Milgrom A, Lee K, Rothschild M, et al. Thrombophilia in 153 Patients With Premature Cardiovascular Disease≤Age 45[J]. Clin Appl Thromb Hemost, 2018, 24(2): 295-302.
|
| [19] |
Wang M, Zhang G, Chen J, et al. Current prevalence of perioperative early venous thromboembolism and risk factors in Chinese adult patients with inguinal hernia(CHAT-1)[J]. Sci Rep, 2020, 10: 12667.
|
| [20] |
中华医学会外科学分会疝与腹壁外科学组, 中国医师协会外科医师分会疝和腹壁外科医师委员会. 成人腹股沟疝诊断和治疗指南(2018年版)[J/OL]. 中华疝和腹壁外科杂志(电子版), 2018, 12(4): 244-246.
|
| [21] |
Fleming FJ, Kim MJ, Salloum RM, et al. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database[J]. Dis Colon Rectum, 2010, 53: 1355-1360.
|
| [22] |
Rosenfeld BA, Beattie C, Christopherson R, et al. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group[J]. Anesthesiology, 1993, 79(3): 435-443.
|
| [23] |
张杰, 张桃, 宁伟伟, 等．腹股沟疝术后发生静脉血栓栓塞症的影响因素分析[J]. 中华消化外科杂志, 2020, 19(7): 751-756.
|
| [24] |
Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting(ENDORSE study): a multinational cross-sectional study[J]. Lancet, 2008, 371(9610): 387-394.
|
| [25] |
Caprini JA. Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005, 51(2/3): 70-78.
|
| [26] |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score[J]. Thromb Haemost, 2010, 8(11): 2450-2457.
|
| [27] |
Autar R. Nursing assessment of clients at risk of deep vein thrombosis(DVT): the Autar DVT scale[J]. J Adv Nurs, 1996, 23: 763-770.
|
| [28] |
Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients[J]. N Engl J Med, 2005, 352: 969-977.
|
| [29] |
Zhou HX, Peng LQ, Yan Y, et al. Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism[J]. Thromb Res, 2012, 130(5): 735-740.
|
| [30] |
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
|
| [31] |
符伟国, 王利新. 围手术期静脉血栓栓塞疾病诊治争议与共识[J]. 中国实用外科杂志, 2015, 35(1): 66-68, 71.
|
| [32] |
Guanella R, Righini M. Serial limited versus single complete compression ultrasonography for the diagnosis of lower extremity deep vein thrombosis[J]. Semin Respir Crit Care Med, 2012, 33(2): 144-150.
|
| [33] |
Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med, 2006, 354(22): 2317-2327.
|
| [34] |
McRae SJ, Ginsberg JS. Update in the diagnosis of deep-vein thrombosis and pulmonary embolism[J]. Curr Opin Anaesthesiol, 2006, 19(1): 44-51.
|
| [35] |
Siniscalchi C. Protective role of statins during anticoagulation for venous thromboembolism: beyond their lipid lowering effect?[J]. Eur J Intern Med, 2020, 79: 127-129.
|
| [36] |
Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial[J]. Lancet, 2009, 373(9670): 1175-1182.
|
| [37] |
Mahmoodi BK, Cushman M, Anne Næss I, et al. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies[J]. Circulation, 2017, 135(1): 7-16.
|
| [38] |
Zöller B, Li X, Sundquist J, et al. Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: a nationwide epidemiological study[J]. Thromb Res, 2012, 129(5): 577-582.
|
| [39] |
Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use[J]. Thromb Haemost, 2003, 89(3): 493-498.
|
| [40] |
Roach RE, Lijfering WM, Flinterman LE, et al. Increased risk of CVD after VT is determined by common etiologic factors[J]. Blood, 2013, 121(24): 4948-4954.
|
| [41] |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2): 315-352.
|
| [42] |
Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function[J]. Eur Heart J, 2018, 39(47): 4208-4218.
|
| [43] |
Schindewolf M, Weitz JI. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment[J]. Thromb Haemost, 2020, 120(1): 14-26.
|
| [44] |
Baker PM, Keeling DM. A single dose of Low-molecular-weight Heparin(LMWH) invalidates the use of D-dimer as part of a Deep Vein Thrombosis(DVT) diagnostic algorithm[J]. Int J Lab Hematol, 2017, 39(1): e17-e18.
|
| [45] |
De Athayde Soares R, Matielo MF, Brochado Neto FC, et al. Reply to: On the questionable ethics of randomizing patients with acute DVT to receive rivaroxaban or warfarin[J]. Surgery, 2020, 167(2): 515-516.
|
| [46] |
Amin A, Marrs JC. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes[J]. Clin Appl Thromb Hemost, 2016, 22(7): 605-616.
|
| [47] |
吴丹明, 张立魁. 腹部外科围手术期下肢深静脉血栓的预防与治疗[J]. 中国实用外科杂志, 2015, 35(12): 1285-1289.
|
| [48] |
刘坚军, 董智慧, 符伟国. 普通外科围手术期静脉血栓栓塞症防治中血管外科干预原则与策略[J]. 中国实用外科杂志, 2020, 40(5): 515-519.
|
| [49] |
Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e419S-e496S.
|
| [50] |
Brunson A, Ho G, White R, et al. Inferior vena cava filters in patients with cancer and venous thromboembolism(VTE) does not improve clinical outcomes: A population-based study[J]. Thromb Res, 2017, 153(1): 57-64.
|